Cadonilimab Combination Demonstrates Promising Survival Benefit in Locally Advanced Pancreatic Cancer: Phase II COMPASSION-26 Data Presented at AACR 2026

B HONG KONG, April 20, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) today announced that positive Phase II results from the COMPASSION-26…
posteditor
posteditor
Articles: 21727

Other News